Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 25;12:636061. doi: 10.3389/fimmu.2021.636061

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Borchers, Santos-Valente, Toncheva, Wehkamp, Franke, Gaertner, Nordkild, Genuneit, Jensen and Kabesch

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Total and differential cell counts (eosinophils, neutrophils, macrophages, and lymphocytes) in bronchoalveolar lavage fluid (A) and concentration of inflammatory cytokines (TNFα, IL-4, IL-5, IL-6, IL-9, IL-13, and IL-33) in lung homogenates of the 3 treatment groups (n=12 per group) (B). Saline: mice sensitized with saline + CFA only (group 1). vehicle/HDM: mice sensitized with HDM at day 0, prophylactic treatment with vehicle at days 12 to 14, and challenge with HDM at day 14 (group 2). hBD-2/HDM: mice sensitized with HDM at day 0, prophylactic treatment with hBD-2 at days 12 to 14, and challenge with HDM at day 14 (group 3). *p < 0.05 when compared to other groups (ANOVA with post-hoc t-test,). hBD-2, human beta-defensin 2; HDM, house dust mite.